Literature DB >> 22194028

Time management in radiation oncology: development and evaluation of a modular system based on the example of rectal cancer treatment. The DEGRO-QUIRO trial.

R Fietkau1, W Budach, N Zamboglou, H-J Thiel, H Sack, W Popp.   

Abstract

PURPOSE: The goal was to develop and evaluate a modular system for measurement of the work times required by the various professional groups involved in radiation oncology before, during, and after serial radiation treatment (long-term irradiation with 25-28 fractions of 1.8 Gy) based on the example of rectal cancer treatment.
MATERIALS AND METHODS: A panel of experts divided the work associated with providing radiation oncology treatment into modules (from the preparation of radiotherapy, RT planning and administration to the final examination and follow-up). The time required for completion of each module was measured by independent observers at four centers (Rostock, Bamberg, Düsseldorf, and Offenbach, Germany).
RESULTS: A total of 1,769 data sets were collected from 63 patients with 10-489 data sets per module. Some modules (informed consent procedure, routine treatments, CT planning) exhibited little deviation between centers, whereas others (especially medical and physical irradiation planning) exhibited a wide range of variation (e.g., 1 h 49 min to 6 h 56 min for physical irradiation planning). The mean work time per patient was 12 h 11 min for technicians, 2 h 59 min for physicists, and 7 h 6 min for physicians.
CONCLUSION: The modular system of time measurement proved to be reliable and produced comparable data at the different centers. Therefore, the German Society of Radiation Oncology (DEGRO) decided that it can be extended to other types of cancer (head and neck, prostate, and breast cancer) with appropriate modifications.

Entities:  

Mesh:

Year:  2011        PMID: 22194028     DOI: 10.1007/s00066-011-0003-1

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  13 in total

1.  Time and motion study of radiotherapy delivery: Economic burden of increased quality assurance and IMRT.

Authors:  Evelyn Van de Werf; Yolande Lievens; Jan Verstraete; Kris Pauwels; Walter Van den Bogaert
Journal:  Radiother Oncol       Date:  2009-09-03       Impact factor: 6.280

2.  Radiotherapy cost-calculation and its impact on capacity planning.

Authors:  Yolande Lievens; Berend Jan Slotman
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2003-08       Impact factor: 2.217

3.  Optimizing the quality of breast cancer care at certified german breast centers: a benchmarking analysis for 2003-2009 with a particular focus on the interdisciplinary specialty of radiation oncology.

Authors:  Sara Y Brucker; Markus Wallwiener; Rolf Kreienberg; Walter Jonat; Matthias W Beckmann; Michael Bamberg; Diethelm Wallwiener; Rainer Souchon
Journal:  Strahlenther Onkol       Date:  2011-01-21       Impact factor: 3.621

4.  [Costs-proceeds calculation for radiotherapy; comment].

Authors:  H J Thiel; W A Oechsler; B Kastura; J Meier; T Schneider; K Freundl; M Dinkel
Journal:  Strahlenther Onkol       Date:  1996-03       Impact factor: 3.621

5.  Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project.

Authors:  Søren M Bentzen; Germaine Heeren; Brian Cottier; Ben Slotman; Bengt Glimelius; Yolande Lievens; Walter van den Bogaert
Journal:  Radiother Oncol       Date:  2005-03-16       Impact factor: 6.280

6.  Japanese structure survey of radiation oncology in 2007 with special reference to designated cancer care hospitals.

Authors:  Hodaka Numasaki; Hitoshi Shibuya; Masamichi Nishio; Hiroshi Ikeda; Kenji Sekiguchi; Norihiko Kamikonya; Masahiko Koizumi; Masao Tago; Yutaka Ando; Nobuhiro Tsukamoto; Atsuro Terahara; Katsumasa Nakamura; Michihide Mitsumori; Tetsuo Nishimura; Masato Hareyama; Teruki Teshima
Journal:  Strahlenther Onkol       Date:  2011-02-21       Impact factor: 3.621

7.  Prostate cancer radiotherapy in Austria: overview on number of patients, intention to treat, and treatment techniques based on data from 2007.

Authors:  Gregor Goldner; Samir Sljivic; Renee Oismueller; Johanna Salinger; Michael Mittermüller; Tanja Langsenlehner; Walter Harder; Gerhard Kametriser; Helmut Eiter; Elisabeth Nechvile
Journal:  Strahlenther Onkol       Date:  2011-04-26       Impact factor: 3.621

8.  Evaluation of time, attendance of medical staff, and resources during radiotherapy for head and neck cancer patients: the DEGRO-QUIRO trial.

Authors:  Wilfried Budach; Edwin Bölke; Rainer Fietkau; Andre Buchali; Thomas G Wendt; Wolfgang Popp; Christiane Matuschek; Horst Sack
Journal:  Strahlenther Onkol       Date:  2011-07-22       Impact factor: 3.621

Review 9.  [Geriatrics and radiation oncology. Part 1: How to identify high-risk patients and basic treatment principles].

Authors:  Franziska Fels; Johannes W Kraft; Gerhard G Grabenbauer
Journal:  Strahlenther Onkol       Date:  2010-07-29       Impact factor: 3.621

10.  Japanese structure survey of radiation oncology in 2005 based on institutional stratification of patterns of care study.

Authors:  Teruki Teshima; Hodaka Numasaki; Hitoshi Shibuya; Masamichi Nishio; Hiroshi Ikeda; Hisao Ito; Kenji Sekiguchi; Norihiko Kamikonya; Masahiko Koizumi; Masao Tago; Yasushi Nagata; Hidekazu Masaki; Tetsuo Nishimura; Shogo Yamada
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-18       Impact factor: 7.038

View more
  15 in total

1.  Evaluation of time, attendance of medical staff and resources for radiotherapy in pediatric and adolescent patients. The DEGRO-QUIRO trial.

Authors:  Angelika Zabel-du Bois; Stefanie Milker-Zabel; Frank Bruns; Hans Christiansen; Iris Ernst; Normann Willich; Wolfgang Popp; Jürgen Debus; Horst Sack
Journal:  Strahlenther Onkol       Date:  2014-04-01       Impact factor: 3.621

2.  Time management in radiation oncology: evaluation of time, attendance of medical staff, and resources during radiotherapy for prostate cancer: the DEGRO-QUIRO trial.

Authors:  L Keilholz; J Willner; H-J Thiel; N Zamboglou; H Sack; W Popp
Journal:  Strahlenther Onkol       Date:  2013-10-16       Impact factor: 3.621

3.  The QUIRO Study (assurance of quality and innovation in radiooncology): methodology, instruments and practices.

Authors:  J Dunst; N Willich; H Sack; R Engenhart-Cabillic; V Budach; W Popp
Journal:  Strahlenther Onkol       Date:  2014-01-11       Impact factor: 3.621

4.  Evaluation of time, attendance of medical staff, and resources during interstitial brachytherapy for prostate cancer : DEGRO-QUIRO trial.

Authors:  N Tselis; U Maurer; W Popp; H Sack; N Zamboglou
Journal:  Strahlenther Onkol       Date:  2014-02-07       Impact factor: 3.621

5.  [Personnel requirements of medical radiation physics in radiotherapy in comparison to the current guidelines "radiation protection in medicine" : Special consideration of intensity-modulated radiation therapy].

Authors:  H-K Leetz; H H Eipper; H Gfirtner; P Schneider; K Welker
Journal:  Strahlenther Onkol       Date:  2014-05-08       Impact factor: 3.621

6.  Evaluation of time, attendance of medical staff, and resources during radiotherapy for breast cancer patients. The DEGRO-QUIRO trial.

Authors:  E Blank; N Willich; R Fietkau; W Popp; J Schaller-Steiner; H Sack; F Wenz
Journal:  Strahlenther Onkol       Date:  2012-01-14       Impact factor: 3.621

7.  Protection of quality and innovation in radiation oncology: the prospective multicenter trial QUIRO of DEGRO: evaluation of time, attendance of medical staff, and resources during radiotherapy with tomotherapy.

Authors:  Cornelia Winkler; M N Duma; W Popp; H Sack; V Budach; M Molls; S Kampfer
Journal:  Strahlenther Onkol       Date:  2014-03-22       Impact factor: 3.621

8.  Radiotherapy infrastructure and human resources in Switzerland : Present status and projected computations for 2020.

Authors:  Niloy Ranjan Datta; Shaka Khan; Dietmar Marder; Daniel Zwahlen; Stephan Bodis
Journal:  Strahlenther Onkol       Date:  2016-07-25       Impact factor: 3.621

9.  Time evaluation of image-guided radiotherapy in patients with spinal bone metastases. A single-center study.

Authors:  H Rief; D Habermehl; K Schubert; J Debus; S E Combs
Journal:  Strahlenther Onkol       Date:  2014-01-16       Impact factor: 3.621

10.  [Database supported electronic retrospective analyses in radiation oncology: establishing a workflow using the example of pancreatic cancer].

Authors:  K A Kessel; D Habermehl; C Bohn; A Jäger; R O Floca; L Zhang; N Bougatf; R Bendl; J Debus; S E Combs
Journal:  Strahlenther Onkol       Date:  2012-10-31       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.